eIFU Compliance Starts with Validation

Electronic Instructions for Use (eIFU) systems must be validated to ensure they meet the stringent requirements set out in EU regulations. Without proper validation, manufacturers risk non-compliance, failed audits, and potential market access issues.

This article explores why validation is the cornerstone of eIFU compliance and what manufacturers need to consider when implementing or evaluating an eIFU platform.

Why Validation Matters for eIFU

Under Regulation (EU) 2021/2226 and its amendments, eIFU systems must guarantee:

• Continuous availability — Users must be able to access IFU at any time
• Data integrity — Information must be accurate, complete, and unaltered
• Version control — Historical versions must be retrievable
• Security — Protection against unauthorized access or modification

These requirements can only be demonstrated through a documented validation process that proves the system performs as intended.

Key Validation Requirements

IEC 62304 Compliance

eIFU platforms are considered medical device software and must follow the Software Development Life Cycle (SDLC) as defined in IEC 62304. This includes:

• Software requirements specification
• Architecture and detailed design
• Implementation and verification
• Risk management integration
• Maintenance procedures

21 CFR Part 11 Principles

While primarily a US regulation, the principles of 21 CFR Part 11 for electronic records are widely adopted:

• Audit trails — All changes must be logged with timestamps and user identification
• Electronic signatures — Where applicable, signatures must be linked to records
• Access controls — Role-based permissions to prevent unauthorized changes

ISO 13485 Quality Management

The eIFU system should be integrated into your Quality Management System (QMS) under ISO 13485, ensuring:

• Document control procedures
• Change management processes
• Supplier qualification (if using third-party platforms)
• Corrective and preventive actions (CAPA)

Common Validation Pitfalls

Many manufacturers underestimate the validation burden of eIFU systems:

1. 1Treating eIFU as "just a website" — Regulators view it as part of your medical device documentation
2. 2Incomplete risk assessments — Failing to identify all potential failure modes
3. 3Missing traceability — No clear link between requirements, tests, and results
4. 4Inadequate change control — Updates deployed without proper validation protocols

The IFUcare Advantage

At IFUcare, we provide a pre-validated eIFU platform that addresses all regulatory requirements:

• Full IEC 62304 documentation — Ready for Notified Body audits
• ISO 13485 & ISO 27001 certified — Quality and security guaranteed
• Comprehensive audit trails — Every action logged and traceable
• 24/7 availability monitoring — Ensuring continuous access worldwide
• Version management — Historical IFU always accessible

By choosing a validated platform, manufacturers can reduce time-to-market and avoid the complexity of building and validating their own systems.

Conclusion

Validation is not optional — it is the foundation of eIFU compliance. Whether you are building an in-house solution or selecting a third-party platform, ensure that validation documentation is complete, audit-ready, and aligned with current regulatory expectations.

IFUcare offers a turnkey solution that lets you focus on your devices while we handle the compliance complexity.